These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets. El Kouni MH Comp Biochem Physiol B Biochem Mol Biol; 2017 Nov; 213():55-80. PubMed ID: 28735972 [TBL] [Abstract][Full Text] [Related]
4. What is the mechanism of action of praziquantel and how might resistance strike? Cupit PM; Cunningham C Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063 [No Abstract] [Full Text] [Related]
5. New insight into praziquantel against various developmental stages of schistosomes. Wu W; Wang W; Huang YX Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370 [TBL] [Abstract][Full Text] [Related]
6. [Study progress on the mode of action of praziquantel against schistosomes]. Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900 [TBL] [Abstract][Full Text] [Related]
7. Schistosomiasis: challenges for control, treatment and drug resistance. Fenwick A; Webster JP Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334 [TBL] [Abstract][Full Text] [Related]
8. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? Bergquist R; Utzinger J; Keiser J Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414 [TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents. Liu LX; Li-Li J; Qiong C; Xiao-Lin F Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801 [TBL] [Abstract][Full Text] [Related]
10. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841 [TBL] [Abstract][Full Text] [Related]
12. Schistosomiasis control: keep taking the tablets. Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023 [TBL] [Abstract][Full Text] [Related]
13. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel]. Guo J; Guo JG Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016 [No Abstract] [Full Text] [Related]
14. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory]. Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812 [TBL] [Abstract][Full Text] [Related]
15. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Doenhoff MJ; Cioli D; Utzinger J Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535 [TBL] [Abstract][Full Text] [Related]
16. [Advances in research on antischistosomal drugs]. Qiu SJ; Xia CM Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510 [TBL] [Abstract][Full Text] [Related]
17. The potential of artemether for the control of schistosomiasis. Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781 [TBL] [Abstract][Full Text] [Related]
18. [Progress in development of new antischistosomal drugs in recent years]. Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Jun; 28(3):218-25. PubMed ID: 20806509 [TBL] [Abstract][Full Text] [Related]
20. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Doenhoff MJ; Pica-Mattoccia L Expert Rev Anti Infect Ther; 2006 Apr; 4(2):199-210. PubMed ID: 16597202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]